Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

Psychotropic drugs can cause hair loss or excessive hair growth.

Changing allopregnanolone levels in baby rats affects their adult behavior and alcohol use.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Finasteride affects brain and blood steroids, causing lasting sexual and emotional side effects.

A new compound shows promise as a topical treatment for hair loss.

δ-GABAA receptors affect alcohol consumption based on the estrous cycle and influence movement regardless of the cycle.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Biodegradable polymers can improve cannabinoid delivery but need more clinical trials.

Drug repurposing shows promise for treating many medical conditions.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Chitosan, a natural substance, can be used to create tiny particles that effectively deliver various types of drugs, but more work is needed to improve stability and control of drug release.

Blue light promotes hair growth by interacting with specific receptors in hair follicles.

Androgen self-administration might be controlled by membrane receptors, not nuclear ones.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

A machine learning model called CATNIP can predict new uses for existing drugs, like using antidepressants for Parkinson's disease and a thyroid cancer drug for diabetes.

Recreational drug use can cause misdiagnosed conditions and drug interactions in HIV patients.

Cannabinoids might help treat skin problems but more research is needed to be sure.

Most drugs fail to reach the market, but understanding their properties and using strategies like early toxicity tests and drug repurposing can help advance their development.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Olfactory receptors found outside the nose may offer new treatments for diseases like cancer and help in wound healing and hair growth.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Sansevieria trifasciata Prain shows promise for treating hair loss by inhibiting androgen receptors.